Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study
Open Access
- 16 June 2026
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 7 (5) , 100852
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Health Outcomes of Discontinuing Antipsychotics After Hospitalization in Older AdultsJAMA Psychiatry, 2025
- Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: A population-based cohort studyJournal of Infection, 2025
- De‐Mystifying the Clone‐Censor‐Weight Method for Causal Research Using Observational Data: A Primer for Cancer ResearchersCancer Medicine, 2024
- Prescription Medication Use Among Older Adults in the USJAMA Internal Medicine, 2024
- Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 PandemicJAMA Psychiatry, 2023
- Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 UpdateDrugs & Aging, 2022
- Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of DementiaJAMA Network Open, 2019
- Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analysesJournal of Clinical Epidemiology, 2016
- Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With DementiaJAMA Psychiatry, 2015
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009